Characterization of α2-adrenergic receptor subtype-specific antibodies

Hitoshi Kurose, J. L. Arriza, R. J. Lefkowitz

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Subtypes of α2-adrenergic receptors have been defined pharmacologically in a variety of mammalian tissues. The α(2A), α(2B), α(2C), and most recently α(2D) subtypes have been characterized by their affinities for selective receptor antagonists and agonists. The genes that may encode the α(2A), α(2B), and α(2C) subtypes have been identified in human and rat. In human these genes are termed α2-C10, α2-C2, and α2-C4, respectively, based on their chromosomal localization, whereas three genes, designated RG20α2, RNGα2, and RG10α2, are thought to be the corresponding rat homologues. These assignments were based on the pharmacology of the cloned receptor genes expressed in transfected cells and on the detection of homologous mRNAs by Northern blot analyses in cell lines or tissues with pharmacologically defined α2-adrenergic receptors. However, the subtype assignment of cloned genes has not been fully resolved by these means. To help clarify the subtype assignment, we have raised antibodies against sequences from the divergent third intracellular loop of the human and rat α2-adrenergic receptors. These antibodies were found to be subtype specific in immunoprecipitating either the cloned receptors expressed by DNA transfection or the pharmacologically defined receptors prepared from various tissues. Our immunological data corroborate the assignments of α2- C2/RNGα2 as encoding the α(2B) subtype in NG108-15 cells and rat neonatal lung and of α2-C4/RG10α2 as encoding the α(2C) subtype in opossum kidney cells. Furthermore, antibodies against α2-C10 and RG20α2 but not α2- C2/RNGα2 or α2-C4/RG10α2 were both found to recognize α2-adrenergic receptors expressed in rat submaxillary glands and in bovine pineal gland, two tissues with α(2D) pharmacology. Because three genes were identified in the rat and human genome, these data suggest that the pharmacologically defined 'α(2D) receptor' is genetically of the α(2A) subtype.

Original languageEnglish
Pages (from-to)444-450
Number of pages7
JournalMolecular Pharmacology
Volume43
Issue number3
Publication statusPublished - Jan 1 1993
Externally publishedYes

Fingerprint

Adrenergic Receptors
Antibodies
Genes
Pharmacology
Opossums
Pineal Gland
Submandibular Gland
Human Genome
Northern Blotting
Transfection
Kidney
Cell Line
Lung
Messenger RNA

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Pharmacology

Cite this

Characterization of α2-adrenergic receptor subtype-specific antibodies. / Kurose, Hitoshi; Arriza, J. L.; Lefkowitz, R. J.

In: Molecular Pharmacology, Vol. 43, No. 3, 01.01.1993, p. 444-450.

Research output: Contribution to journalArticle

Kurose, H, Arriza, JL & Lefkowitz, RJ 1993, 'Characterization of α2-adrenergic receptor subtype-specific antibodies', Molecular Pharmacology, vol. 43, no. 3, pp. 444-450.
Kurose, Hitoshi ; Arriza, J. L. ; Lefkowitz, R. J. / Characterization of α2-adrenergic receptor subtype-specific antibodies. In: Molecular Pharmacology. 1993 ; Vol. 43, No. 3. pp. 444-450.
@article{d39713d24b7943ef861d53c97d4f8104,
title = "Characterization of α2-adrenergic receptor subtype-specific antibodies",
abstract = "Subtypes of α2-adrenergic receptors have been defined pharmacologically in a variety of mammalian tissues. The α(2A), α(2B), α(2C), and most recently α(2D) subtypes have been characterized by their affinities for selective receptor antagonists and agonists. The genes that may encode the α(2A), α(2B), and α(2C) subtypes have been identified in human and rat. In human these genes are termed α2-C10, α2-C2, and α2-C4, respectively, based on their chromosomal localization, whereas three genes, designated RG20α2, RNGα2, and RG10α2, are thought to be the corresponding rat homologues. These assignments were based on the pharmacology of the cloned receptor genes expressed in transfected cells and on the detection of homologous mRNAs by Northern blot analyses in cell lines or tissues with pharmacologically defined α2-adrenergic receptors. However, the subtype assignment of cloned genes has not been fully resolved by these means. To help clarify the subtype assignment, we have raised antibodies against sequences from the divergent third intracellular loop of the human and rat α2-adrenergic receptors. These antibodies were found to be subtype specific in immunoprecipitating either the cloned receptors expressed by DNA transfection or the pharmacologically defined receptors prepared from various tissues. Our immunological data corroborate the assignments of α2- C2/RNGα2 as encoding the α(2B) subtype in NG108-15 cells and rat neonatal lung and of α2-C4/RG10α2 as encoding the α(2C) subtype in opossum kidney cells. Furthermore, antibodies against α2-C10 and RG20α2 but not α2- C2/RNGα2 or α2-C4/RG10α2 were both found to recognize α2-adrenergic receptors expressed in rat submaxillary glands and in bovine pineal gland, two tissues with α(2D) pharmacology. Because three genes were identified in the rat and human genome, these data suggest that the pharmacologically defined 'α(2D) receptor' is genetically of the α(2A) subtype.",
author = "Hitoshi Kurose and Arriza, {J. L.} and Lefkowitz, {R. J.}",
year = "1993",
month = "1",
day = "1",
language = "English",
volume = "43",
pages = "444--450",
journal = "Molecular Pharmacology",
issn = "0026-895X",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "3",

}

TY - JOUR

T1 - Characterization of α2-adrenergic receptor subtype-specific antibodies

AU - Kurose, Hitoshi

AU - Arriza, J. L.

AU - Lefkowitz, R. J.

PY - 1993/1/1

Y1 - 1993/1/1

N2 - Subtypes of α2-adrenergic receptors have been defined pharmacologically in a variety of mammalian tissues. The α(2A), α(2B), α(2C), and most recently α(2D) subtypes have been characterized by their affinities for selective receptor antagonists and agonists. The genes that may encode the α(2A), α(2B), and α(2C) subtypes have been identified in human and rat. In human these genes are termed α2-C10, α2-C2, and α2-C4, respectively, based on their chromosomal localization, whereas three genes, designated RG20α2, RNGα2, and RG10α2, are thought to be the corresponding rat homologues. These assignments were based on the pharmacology of the cloned receptor genes expressed in transfected cells and on the detection of homologous mRNAs by Northern blot analyses in cell lines or tissues with pharmacologically defined α2-adrenergic receptors. However, the subtype assignment of cloned genes has not been fully resolved by these means. To help clarify the subtype assignment, we have raised antibodies against sequences from the divergent third intracellular loop of the human and rat α2-adrenergic receptors. These antibodies were found to be subtype specific in immunoprecipitating either the cloned receptors expressed by DNA transfection or the pharmacologically defined receptors prepared from various tissues. Our immunological data corroborate the assignments of α2- C2/RNGα2 as encoding the α(2B) subtype in NG108-15 cells and rat neonatal lung and of α2-C4/RG10α2 as encoding the α(2C) subtype in opossum kidney cells. Furthermore, antibodies against α2-C10 and RG20α2 but not α2- C2/RNGα2 or α2-C4/RG10α2 were both found to recognize α2-adrenergic receptors expressed in rat submaxillary glands and in bovine pineal gland, two tissues with α(2D) pharmacology. Because three genes were identified in the rat and human genome, these data suggest that the pharmacologically defined 'α(2D) receptor' is genetically of the α(2A) subtype.

AB - Subtypes of α2-adrenergic receptors have been defined pharmacologically in a variety of mammalian tissues. The α(2A), α(2B), α(2C), and most recently α(2D) subtypes have been characterized by their affinities for selective receptor antagonists and agonists. The genes that may encode the α(2A), α(2B), and α(2C) subtypes have been identified in human and rat. In human these genes are termed α2-C10, α2-C2, and α2-C4, respectively, based on their chromosomal localization, whereas three genes, designated RG20α2, RNGα2, and RG10α2, are thought to be the corresponding rat homologues. These assignments were based on the pharmacology of the cloned receptor genes expressed in transfected cells and on the detection of homologous mRNAs by Northern blot analyses in cell lines or tissues with pharmacologically defined α2-adrenergic receptors. However, the subtype assignment of cloned genes has not been fully resolved by these means. To help clarify the subtype assignment, we have raised antibodies against sequences from the divergent third intracellular loop of the human and rat α2-adrenergic receptors. These antibodies were found to be subtype specific in immunoprecipitating either the cloned receptors expressed by DNA transfection or the pharmacologically defined receptors prepared from various tissues. Our immunological data corroborate the assignments of α2- C2/RNGα2 as encoding the α(2B) subtype in NG108-15 cells and rat neonatal lung and of α2-C4/RG10α2 as encoding the α(2C) subtype in opossum kidney cells. Furthermore, antibodies against α2-C10 and RG20α2 but not α2- C2/RNGα2 or α2-C4/RG10α2 were both found to recognize α2-adrenergic receptors expressed in rat submaxillary glands and in bovine pineal gland, two tissues with α(2D) pharmacology. Because three genes were identified in the rat and human genome, these data suggest that the pharmacologically defined 'α(2D) receptor' is genetically of the α(2A) subtype.

UR - http://www.scopus.com/inward/record.url?scp=0027457821&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027457821&partnerID=8YFLogxK

M3 - Article

VL - 43

SP - 444

EP - 450

JO - Molecular Pharmacology

JF - Molecular Pharmacology

SN - 0026-895X

IS - 3

ER -